• Ueland PM, Refsum H, Brattstrøm L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed.
    Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York, USA: Marcel Dekker inc., 1992; 183–236.
  • 2
    Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049 57.
  • 3
    Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 22: 1775 81.
  • 4
    Miller JW, Ribaya-Mercado JD, Russell RM, Shepard DC, Morrow FD, Cochary EF et al. Effect of vitamin B6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr 1992; 55: 1154 60.
  • 5
    Carlsen SM, Følling I, Grill V, Bjerve KS, Schneede J, Refsum H. Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease. Scand J Clin Lab Invest 1997; 57: 521 28.
  • 6
    Savage DG, Lindenbaum J, Stabler SP, Allan RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239 46.
  • 7
    Bailey CF. Metformin: an update. Gen Pharmac 1993; 24: 1299 309.
  • 8
    Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263 71.
  • 9
    Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989; 35: 1921 27.
  • 10
    Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE et al. Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. JAMA 1995; 274: 1526 33.
  • 11
    Ueland PM, Refsum H, Stabler SP, Malinov MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764 79.
  • 12
    Brattström L, Israelsson B, Jeppson JO, Hultberg B. Folic acid: an innocuous means of reducing plasma homocysteine. Scand J Clin Lab Invest 1988; 48: 215 21.
  • 13
    Ubbink JB, Vermaak WJH, Van Der Merwe A, Becker PJ, Delport R, Potgieter H. Vitamin requirements for the treatment of hyperhomocysteinaemia in humans. J Nutr 1994; 124: 1927 33.
  • 14
    Callaghan TS, Hadden DR, Tomkin GH. Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment. Br Med J 1980; 17: 1214 15.
  • 15
    Mourits-Anderson T & Ditzel J. Megaloblastær anæmi forårsaget af vitamin B12 malabsorption under langvarig metforminbehandling. Ugeskrift for Læger 1983; 145: 25 26.
  • 16
    Ubbink JB, Vermaak WJH, Van Der Merwe A, Becker PJ. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinaemia . Am J Clin Nutr 1993; 57: 47 53.
  • 17
    Ubbink JB, Van Der Merwe A, Vermaak WJH, Delport R. Hyperhomocysteinaemia and the response to vitamin supplementation. Clin Invest 1993; 71: 993 98.
  • 18
    Arnadottir M, Brattström L, Simonsen O, Thysell H, Hultberg B, Andersson A, Nilsson-Ehle P. The effect of high-dose pyridoxine and folic acid supplementation on serum lipids and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993; 40: 236 40.
  • 19
    Brattström L. Vitamins as homocysteine-lowering agents. J Nutr 1996; 126: 1276 80.
  • 20
    Brattström L, Israelsson B, Norrving B, Bergquist D, Thörne J, Hultberg B, Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51 60.
  • 21
    Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattström L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995; 237: 381 88.
  • 22
    Van den Berg M, Franken DG, Boers GHJ, Blom HJ, Jakobs C, Stehouwer CDA, Rauwerda JA. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinaemia. J Vasc Surg 1994; 20: 933 40.
  • 23
    Brattström L, Hultberg BL, Hardebo JE. Folic acid responsive post menopausal homocysteinaemia. Metabolism 1985; 34: 1073 7.